Ashley D. Giourdas

Ashley D. Giourdas

Auto-generated profile, based on publicly available information

Ashley D. Giourdas

Indiana University

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Verified
Journal Article
Closed access
GLGary Marshall Long
Gary Marshall Long
AGAshley D. Giourdas
Ashley D. Giourdas
AFAmanda J. Fisher
Amanda J. Fisher
TLTim Lahm
Tim Lahm
ACAndrew Coggan
Andrew Coggan
MBMary Beth Brown
Mary Beth Brown
Skeletal muscle dysfunction contributes to exercise intolerance in patients with pulmonary arterial hypertension (PAH). Reduced blood flow to skeletal muscle has been demonstrated in a rat model of the disease. We investigated the effect of acute nitrate (NO3−) ingestion via beetroot juice (BRJ) on exercising muscle blood flow, and on plasma and muscle nitrate (NO3−), nitrite (NO2−) and cyclic GMP (cGMP) in male Sprague Dawley rats (~200 g, n=24) with monocrotaline-induced (60 mg/kg) PH. Muscle blood flow was assessed at rest and during treadmill running using fluorescent microspheres. Despite higher plasma NO3− (756 ± 118 vs 63 ± 22 μmol/L p=<0.001) and NO2− (0.63 ± 0.10 vs. 0.24 ± 0.04 μmol/L p=0.003), no difference between BRJ and PL was observed in either resting (p=0.88) or exercising (p=0.42) blood flow. Only NO3− was higher in BRJ vs. PL for both the soleus (sol: 261 ± 20 vs. 123 ± 18 vs μmol/kg, p=<0.0005) and vastus lateralis (VL: 176 ± 34 vs. 86 ± 14 μmol/kg, p=0.02), with no differences for NO2− (sol: 1.9 ± 0.2 vs.1.7 ± 0.3 μmol/kg, p=0.49; VL: 1.04 ± 0.2 vs. 1.03 ± 0.2 μmol/kg, p=0.97) or cGMP (sol: 4.8 ± 2.1 vs. 3.9 ± 1.5 vs. nmol/kg, p=0.22; VL 6.0 ± 3.8 vs. 5.8 ±3.2 nmol/kg, p=0.91). In a rat model of severe PH, acute BRJ dosing increases circulating and muscle NO3− but does not alter muscle blood flow. Absence of change in muscle NO2− and cGMP suggest insufficiently altered downstream NO signaling with BRJ supplementation.